Catalyst Pharmaceuticals(CPRX) Newsfilter·2025-02-12 13:03Core Viewpoint - Catalyst Pharmaceuticals, Inc. is set to release its fourth quarter and full-year 2024 financial results on February 26, 2025, followed by a conference call on February 27, 2025, to discuss these results and provide a business update [1][2]. Company Overview - Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing and commercializing novel medicines for patients with rare and difficult-to-treat diseases [1][4]. - The company has a proven track record of bringing life-changing treatments to market and emphasizes patient care and accessibility through comprehensive support services [4]. - Catalyst is headquartered in Coral Gables, FL, and has been recognized on the Forbes 2025 list as one of America's most successful mid-cap companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's fastest-growing companies [4]. Conference Call & Webcast Details - The conference call and webcast will take place on February 27, 2025, at 8:30 AM ET, with dial-in numbers provided for US/Canada and international participants [2][3]. - The webcast will be accessible on the company's website, and a replay will be available for at least 30 days following the event [3].